The CEO's large open-market sale after a strong earnings beat is a cautionary signal. While the company's fundamentals are improving (23% revenue growth, raised guidance), the insider cluster suggests management may view the stock as fairly valued or ahead of near-term catalysts. Monitor for additional insider filings in the next 30 days; if the CEO or other C-suite executives continue selling, it would reinforce the bearish read. The stock's 94% analyst bullish consensus creates a potential divergence between street sentiment and insider behavior.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 17 $124.41entry
- T+1 · 3mo ago −6.68%α −6.00% · $116.10
- T+5 · 3mo ago +13.17%α +14.36% · $140.80
- T+20 · 2mo ago +11.00%α +12.98% · $138.10
- T+60 · 7d ago +6.21%α +9.15% · $132.13
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Twist Bioscience CEO Emily Leproust sold $14.2M of stock via a derivative exercise-and-sell transaction, while two directors and another executive also sold shares totaling ~$18.1M in the week following a strong Q3 earnings beat. The cluster is dominated by the CEO's open-market sale, which is the largest insider sell at the company in the past 30 days ($18.7M total prior). The sales follow an earnings report that beat consensus and raised guidance, but the CEO's sale is a large, non-10b5-1 disposition that may signal limited upside at current levels near $125.
Key Financial Metrics
Key Facts
- CEO Emily Leproust sold 113,318 shares on 2026-08-10 at ~$125.16, netting $14.18M in open-market proceeds after exercising options at $26.66.
- Director Katryn Blake sold 2,240 shares at $122.88 for $275K on 2026-08-12.
- Director Robert Chess sold 18,400 shares at $110.89 for $2.04M on 2026-08-07.
- Executive Dennis Cho sold 14,200 shares at $109.75 for $1.56M on 2026-08-05.
- Total cluster value: $18.06M, representing ~0.22% of Twist's $8.3B market cap.
- The cluster follows Twist's fiscal Q3 2026 earnings beat (revenue $118.4M vs. $114.5M consensus) and raised FY2026 guidance to $456-457M.
- The CEO's sale is not a 10b5-1 plan transaction; it is a same-day exercise-and-sell.
Financial Impact
$18.06M in insider sales, 0.22% of market cap, modest in proportion but significant in signal given CEO participation.
Risk Factors
- CEO sale may be liquidity-driven (option exercise to fund taxes or diversification) rather than a negative signal.
- Company's strong earnings momentum (14th consecutive quarter of sequential growth) could continue to drive the stock higher despite insider selling.
- Insider sales represent only 0.22% of market cap, not large enough to materially impact stock price.
- Analyst consensus is 94% bullish, which may create a contrarian headwind if the stock has already priced in good news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TWST-1786738733768 |
Track record
47 reports on TWST
8 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $105.04 +0.01% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $105.04 −0.11% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $105.04 +0.06% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $105.04 −0.54% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $105.04 +0.98% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $105.04 −20.50% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $105.04 −13.04% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $105.04 −12.91% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers